Evotec AG and Roche today announced a collaboration in novel protein-activity based biomarkers for Roche’s oncology drugs under development. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-roche-to-jointly-develop-biomarkers-in-oncology-5008